Gene · 1301
Papers2,518
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,518
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Hepatocellular Carcinoma Subtypes Based on Global Gene Expression Profiling to Predict the Prognosis and Potential Therapeutic Drugs. | Biomedicines | 2025 | 39857819 | PubTator, text mining | PubMed |
| The Dynamic Changes of COL11A1 Expression During the Carcinogenesis and Development of Breast Cancer and as a Candidate Diagnostic and Prognostic Marker. | Breast J | 2025 | 39845732 | PubTator, text mining | PubMed |
| Genome sequencing reveals novel variants in a diverse population with congenital anterior segment anomalies. | Sci Rep | 2025 | 39747279 | PubTator, text mining | PubMed |
| Ophthalmic Manifestations in a Diverse Pediatric Population with Type I and Type II Stickler Syndrome. | Ophthalmol Retina | 2025 | 39675476 | PubTator, text mining | PubMed |
| Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer. | Nat Genet | 2025 | 39658657 | PubTator, text mining | PubMed |
| Effect of COL11A1 on oral squamous cell carcinoma. | J Stomatol Oral Maxillofac Surg | 2025 | 39631528 | PubTator, text mining | PubMed |
Fibroblast Activation Protein-α Expression in Cancer-Associated Fibroblasts Shows the Poor Survival of Colorectal Cancer via Immune-Mediated Pathways : Implications of FAP in Cancer-Associated Fibroblasts Link Immune Dysregulation to Adverse Survival in Colorectal Cancer. | Ann Surg Oncol | 2025 | 39623187 | PubTator, text mining | PubMed |
| Heterozygous COL11A1 mutation associated with congenital cataract, lens subluxation, and zonular loss. | Can J Ophthalmol | 2025 | 39542031 | PubTator, text mining | PubMed |
| Retinal detachment in Type IX collagen recessive Stickler syndrome. | Eye (Lond) | 2025 | 39406934 | PubTator, text mining | PubMed |
| Screening for Biomarkers Related to Pigmentation and Formation in Vitiligo. | Comb Chem High Throughput Screen | 2025 | 38231049 | PubTator, text mining | PubMed |
| Genetic Variants in Rare Ophthalmological Syndromes: Novel COL11A1 Splice Site Variant in a Brazilian Family with Stickler Syndrome Type 2. | J Curr Ophthalmol | 2024 | 40557406 | PubTator, text mining | PubMed |
| Ocular Biometry and Genomic Association in Primary Angle Closure Disease. A Descriptive study. | Rom J Ophthalmol | 2024 | 39936063 | PubTator, text mining | PubMed |
| [Development of prognostic clinical and genetic models of the risk of low bone mineral density using neural network training]. | Probl Endokrinol (Mosk) | 2024 | 39868449 | PubTator, text mining | PubMed |
| Heterogeneous Group of Genetically Determined Auditory Neuropathy Spectrum Disorders. | Int J Mol Sci | 2024 | 39684270 | PubTator, text mining | PubMed |
| Efficient multi-phenotype genome-wide analysis identifies genetic associations for unsupervised deep-learning-derived high-dimensional brain imaging phenotypes. | medRxiv | 2024 | 39677479 | PubTator, text mining | PubMed |
| Phenotypic and Genetic Spectrum in 309 Consecutive Pediatric Patients with Inherited Retinal Disease. | Int J Mol Sci | 2024 | 39596324 | PubTator, text mining | PubMed |
| Innovative pan-tumor target strategy for CAR-T therapy: cancer-specific exons as novel targets for pediatric solid and brain tumors. | J Transl Med | 2024 | 39533264 | PubTator, text mining | PubMed |
| Bioinformatics analysis and experimental validation of the oncogenic role of COL11A1 in pan-cancer. | 3 Biotech | 2024 | 39507058 | PubTator, text mining | PubMed |
| Fatty acid metabolism prognostic signature predicts tumor immune microenvironment and immunotherapy, and identifies tumorigenic role of MOGAT2 in lung adenocarcinoma. | Front Immunol | 2024 | 39478862 | PubTator, text mining | PubMed |
| The role of immune cells settled in the bone marrow on adult hematopoietic stem cells. | Cell Mol Life Sci | 2024 | 39367881 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1301/papers?page=8